A Dose of Good News for ImClone; Shares soared Tuesday after a study showed the company's Erbitux could be effective against a form of lung cancer

MLA

Steverman, Ben. “A Dose of Good News for ImClone; Shares Soared Tuesday after a Study Showed the Company’s Erbitux Could Be Effective against a Form of Lung Cancer.” Business Week Online, Sept. 2007. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.168600039&authtype=sso&custid=ns315887.

APA

Steverman, B. (2007, September 12). A Dose of Good News for ImClone; Shares soared Tuesday after a study showed the company’s Erbitux could be effective against a form of lung cancer. Business Week Online.

Chicago

Steverman, Ben. 2007. “A Dose of Good News for ImClone; Shares Soared Tuesday after a Study Showed the Company’s Erbitux Could Be Effective against a Form of Lung Cancer.” Business Week Online, September 12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.168600039&authtype=sso&custid=ns315887.